Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Tissue Engineering & Bioprinting: Research to Commercialization

Paul Dalton's Biography



Paul Dalton, Professor, Functional Materials in Dentistry and Medicine, University of Würzburg, Bavaria

Paul Dalton is a Professor in Biofabrication at the University of Würzburg, Germany. He has 20 years’ of interdisciplinary experience in biomedical materials, including polymer processing, surgery, nanotechnology and surface science. Originally from Perth, Australia, and trained as a materials scientist, he was part of a successful team in the 1990s taking an artificial cornea from concept to the clinic. Paul post-docced at the University of Toronto, Canada, and RWTH Aachen, Germany, working in neural tissue engineering and applying nanotechnology to life science applications. As an independent fellow at the University of Southampton, he invented melt electrospinning writing as a new 3D printing technology and performed experimental surgery to understand the neuro-inflammation of hydrogels in the spinal cord. Between 2010 and 2013, he split his time between Shanghai Jiao Tong University in China and Queensland University of Technology in Australia. Paul has published over 70 research articles in journals including Advanced Materials, Progress in Polymer Science and Nature Materials.

Paul Dalton Image

Melt Electrospinning in a Direct Writing Mode – A New Additive Manufacturing Technology Platform

Monday, 9 February 2015 at 17:30

Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com

It has long been appreciated that the electrostatic drawing (electrospinning) of either polymer solutions or melts is possible.  Research into melt electrospinning, however, is significantly less and comparatively recent - with over half of the melt electrospinning literature being published since 2011.  Even with this recent increase in number of publications, melt electrospinning contributes to less than 1% of the solution electrospinning literature. There is compelling rationale for electrospinning fibres from the melt in certain applications.  The use of solvents can be problematic, and extraction during electrospinning and post-processing are undesired. This is particularly true in biomedical materials applications, where the volatile solvents used in solution electrospinning are also toxic to cells and tissues.  There are also important phenomenological aspects of electrospinning polymer melts, and recent research applying additive manufacturing principles to the process has resulted in new structures for tissue engineering applications.


Add to Calendar ▼2015-02-09 00:00:002015-02-10 00:00:00Europe/LondonTissue Engineering and Bioprinting: Research to CommercializationTissue Engineering and Bioprinting: Research to Commercialization in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com